Role of glucocorticoids in breast cancer

Jayant S. Vaidya, Gustavo Baldassarre, Mangesh A. Thorat, Samuele Massarut

Research output: Contribution to journalArticle

Abstract

Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each other's activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.

Original languageEnglish
Pages (from-to)3593-3600
Number of pages8
JournalCurrent Pharmaceutical Design
Volume16
Issue number32
DOIs
Publication statusPublished - 2010

Fingerprint

Glucocorticoids
Breast Neoplasms
Therapeutics
Hematologic Neoplasms
Immunosuppressive Agents
Menstrual Cycle
Autoimmune Diseases
Arthritis
Embryonic Development
Shock
Epidemiology
Homeostasis
Anti-Inflammatory Agents
Asthma
Drug Therapy
Research
Pharmaceutical Preparations
Neoplasms

Keywords

  • Breast cancer
  • Circadian
  • Glucocorticoid receptor
  • Glucocorticoids
  • Paracrine
  • Review
  • Steroids
  • Treatment

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Role of glucocorticoids in breast cancer. / Vaidya, Jayant S.; Baldassarre, Gustavo; Thorat, Mangesh A.; Massarut, Samuele.

In: Current Pharmaceutical Design, Vol. 16, No. 32, 2010, p. 3593-3600.

Research output: Contribution to journalArticle

Vaidya, Jayant S. ; Baldassarre, Gustavo ; Thorat, Mangesh A. ; Massarut, Samuele. / Role of glucocorticoids in breast cancer. In: Current Pharmaceutical Design. 2010 ; Vol. 16, No. 32. pp. 3593-3600.
@article{88dd2f0442f34679b9a8c7177cf7dae7,
title = "Role of glucocorticoids in breast cancer",
abstract = "Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each other's activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.",
keywords = "Breast cancer, Circadian, Glucocorticoid receptor, Glucocorticoids, Paracrine, Review, Steroids, Treatment",
author = "Vaidya, {Jayant S.} and Gustavo Baldassarre and Thorat, {Mangesh A.} and Samuele Massarut",
year = "2010",
doi = "10.2174/138161210793797906",
language = "English",
volume = "16",
pages = "3593--3600",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "32",

}

TY - JOUR

T1 - Role of glucocorticoids in breast cancer

AU - Vaidya, Jayant S.

AU - Baldassarre, Gustavo

AU - Thorat, Mangesh A.

AU - Massarut, Samuele

PY - 2010

Y1 - 2010

N2 - Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each other's activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.

AB - Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each other's activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.

KW - Breast cancer

KW - Circadian

KW - Glucocorticoid receptor

KW - Glucocorticoids

KW - Paracrine

KW - Review

KW - Steroids

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=78650905197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650905197&partnerID=8YFLogxK

U2 - 10.2174/138161210793797906

DO - 10.2174/138161210793797906

M3 - Article

C2 - 20977423

AN - SCOPUS:78650905197

VL - 16

SP - 3593

EP - 3600

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 32

ER -